Myofibroblasts in Fibrotic Kidneys

Current Pathobiology Reports

Volumn 1, Issue 3, 2013, Pages 189-198

  Nakagawa, Naoki ^a   Duffield, Jeremy S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; FOXD1 progenitors; Glomerular disease; Myofibroblast; Pericytes; Resident fibroblasts

Indexed keywords

EID: 84990188886     PISSN: None     EISSN: 2167485X     Source Type: Journal    
DOI: 10.1007/s40139-013-0025-8     Document Type: Review

References (66)

1. Snyder JJ, Foley RN, Collins AJ (2009) Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 53:218–228. doi:10.1053/j.ajkd.2008.07.034
2. Grgic I, Duffield JS, Humphreys BD (2012) The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 27:183–193. doi:10.1007/s00467-011-1772-6
3. Schrimpf C, Duffield JS (2011) Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 20:297–305. doi:10.1097/MNH.0b013e328344c3d4
4. National Kidney Foundation (2012) KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 60:850–886. doi:10.1053/j.ajkd.2012.07.005
5. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524–529. doi:10.1172/JCI31487
6. Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247–1253. doi:10.1681/ASN.2010060616
7. Kalluri R, Neilson EG (2003) Epithelial–mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776–1784. doi:10.1172/JCI20530
8. Zeisberg M, Kalluri R (2008) Fibroblasts emerge via epithelial–mesenchymal transition in chronic kidney fibrosis. Front Biosci 13:6991–6998
9. •• Humphreys BD, Lin S-L, Kobayashi A et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97. doi:10.2353/ajpath.2010.090517. This study reveals that pericytes, not epithelial cells, are the major source of scar-forming myofibroblasts in animal models of interstitial kidney disease using fate-mapping approaches
10. • Lin S-L, Kisseleva T, Brenner DA, Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617–1627. doi:10.2353/ajpath.2008.080433. This study shows that pericytes and the closely related perivascular fibroblasts are the major source of scar-forming myofibroblasts in animal models of interstitial kidney disease
11. Duffield JS, Humphreys BD (2011) Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 79:494–501. doi:10.1038/ki.2010.338
12. Kisseleva T, Cong M, Paik Y et al (2012) Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci 109:9448–9453. doi:10.1073/pnas.1201840109
13. Bhattacharyya S, Wei J, Varga J (2011) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8:42–54. doi:10.1038/nrrheum.2011.149
14. Gabbiani G, Gabbiani G, Majno G, Majno G (1972) Dupuytren’s contracture: fibroblast contraction? An ultrastructural study. Am J Pathol 66:131–146
15. Duffield JS, Lupher M, Thannickal VJ, Wynn TA (2012) Host responses in tissue repair and fibrosis. Annu Rev Pathol. doi:10.1146/annurev-pathol-020712-163930
16. Krempen K, Grotkopp D, Hall K et al (1999) Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. Gene Expr 8:151–163
17. Fligny C, Duffield JS (2013) Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Curr Opin Rheumatol 25:78–86. doi:10.1097/BOR.0b013e32835b656b
18. Chen Y-T, Chang F-C, Wu C-F et al (2011) Platelet-derived growth factor receptor signaling activates pericyte–myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80:1170–1181. doi:10.1038/ki.2011.208
19. Campanholle G, Ligresti G, Gharib SA, Duffield JS (2013) Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. AJP Cell Physiol 304:C591–C603. doi:10.1152/ajpcell.00414.2012
20. Castano AP, Lin SL, Surowy T et al (2009) Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 1:5ra13–5ra13. doi:10.1126/scitranslmed.3000111
21. • Lin SL, Chang FC, Schrimpf C et al (2011) Targeting endothelium–pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. AJPA 178:911–923. doi:10.1016/j.ajpath.2010.10.012. This study shows links between endothelium and pericytes through VEGF during kidney fibrosis and that attenuated VEGFR2 signaling is beneficial in interstitial kidney disease
22. Lin SL, Castano AP, Nowlin BT et al (2009) Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183:6733–6743. doi:10.4049/jimmunol.0901473
23. Scholten D, Reichart D, Paik YH et al (2011) Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179:189–198. doi:10.1016/j.ajpath.2011.03.049
24. Rock JR, Barkauskas CE, Cronce MJ et al (2011) Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci 108:E1475–E1483. doi:10.1073/pnas.1117988108
25. Smith SW, Eardley KS, Croft AP et al (2011) CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int 80:199–207. doi:10.1038/ki.2011.103
26. Smith SW, Schrimpf C, Parekh DJ et al (2012) Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Histol Histopathol 27:1503–1514
27. Wu C-F, Chiang W-C, Lai C-F et al (2012) Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte–myofibroblast transition in obstructive kidney fibrosis. Am J Pathol. doi:10.1016/j.ajpath.2012.09.009
28. Allt G, Lawrenson JG (2001) Pericytes: cell biology and pathology. Cells Tissues Organs 169:1–11
29. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99–109
30. Bielesz B, Sirin Y, Si H et al (2010) Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120:4040–4054. doi:10.1172/JCI43025
31. Koesters R, Kaissling B, Lehir M et al (2010) Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 177:632–643. doi:10.2353/ajpath.2010.091012
32. Asada N, Takase M, Nakamura J et al (2011) Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121:3981–3990. doi:10.1172/JCI57301
33. Clausen BE, Burkhardt C, Reith W et al (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8:265–277
34. Kida Y, Duffield JS (2011) Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 38:467–473. doi:10.1111/j.1440-1681.2011.05531.x
35. Stratman AN, Malotte KM, Mahan RD et al (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114:5091–5101. doi:10.1182/blood-2009-05-222364
36. Stratman AN, Schwindt AE, Malotte KM, Davis GE (2010) Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 116:4720–4730. doi:10.1182/blood-2010-05-286872
37. Armulik A, Genové G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215. doi:10.1016/j.devcel.2011.07.001
38. Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neurooncology 7:452–464. doi:10.1215/S1152851705000232
39. Rojas A, Chang F-C, Lin S-L, Duffield JS (2012) The role played by perivascular cells in kidney interstitial injury. Clin Nephrol 77:400–408
40. Schrimpf CC, Xin CC, Campanholle GG et al (2012) Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 23:868–883. doi:10.1681/ASN.2011080851
41. Pallone TL, Silldorff EP (2001) Pericyte regulation of renal medullary blood flow. Exp Nephrol 9:165–170
42. Herman IM, D apos Amore PA (1985) Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 101:43–52
43. Peppiatt CM, Howarth C, Mobbs P, Attwell D (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature 443:700–704. doi:10.1038/nature05193
44. Zhang Z, Lin H, Cao C et al (2010) Voltage-gated divalent currents in descending vasa recta pericytes. Am J Physiol Renal Physiol 299:F862–F871. doi:10.1152/ajprenal.00321.2010
45. Zhang W, Pibulsonggram T, Edwards A (2004) Determinants of basal nitric oxide concentration in the renal medullary microcirculation. Am J Physiol Renal Physiol 287:F1189–F1203. doi:10.1152/ajprenal.00125.2004
46. O apos Connor PM, Cowley AW (2012) Medullary thick ascending limb buffer vasoconstriction of renal outer-medullary vasa recta in salt-resistant but not salt-sensitive rats. Hypertension 60:965–972. doi:10.1161/HYPERTENSIONAHA.112.195214
47. Smith SW, Chand S, Savage COS (2012) Biology of the renal pericyte. Nephrol Dial Transplant 27:2149–2155. doi:10.1093/ndt/gfs134
48. Proebstl D, Voisin M-B, Woodfin A et al (2012) Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 209:1219–1234. doi:10.1084/jem.20111622
49. • Ren S, Johnson BG, Kida Y et al (2013) LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 110:1440–1445. doi:10.1073/pnas.1211179110. This study shows the detailed signaling pathways including the dominance of non-canonical WNT pathway signaling involved in pericyte proliferation and activation
50. Basile DP, Fredrich K, Chelladurai B et al (2008) Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 294:F928–F936. doi:10.1152/ajprenal.00596.2007
51. Jönsson-Rylander A-C, Nilsson T, Fritsche-Danielson R et al (2005) Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. Arterioscler Thromb Vasc Biol 25:180–185. doi:10.1161/01.ATV.0000150045.27127.37
52. Yokoi H, Mukoyama M, Nagae T et al (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15:1430–1440
53. He W, Dai C, Li Y et al (2009) Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20:765–776. doi:10.1681/ASN.2008060566
54. Machado FG, Kuriki PS, Fujihara CK et al (2012) Chronic VEGF blockade worsens glomerular injury in the remnant kidney model. PLoS One 7:e39580. doi:10.1371/journal.pone.0039580
55. Eremina V, Jefferson JA, Kowalewska J et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129–1136. doi:10.1056/NEJMoa0707330
56. Salvucci O, Maric D, Economopoulou M et al (2009) EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 114:1707–1716. doi:10.1182/blood-2008-12-192294
57. Foo SS, Turner CJ, Adams S et al (2006) Ephrin-B2 controls cell motility and adhesion during blood–vessel–wall assembly. Cell 124:161–173. doi:10.1016/j.cell.2005.10.034
58. Kida Y, Leronimakis N, Schrimpf C et al (2013) Defective ephrinB2 reverse signaling promotes capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol 24(4):559–572
59. Fabian SL, Penchev RR, St-Jacques B et al (2012) Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 180:1441–1453. doi:10.1016/j.ajpath.2011.12.039
60. Ding H, Zhou D, Hao S et al (2012) Sonic hedgehog signaling mediates epithelial–mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 23:801–813. doi:10.1681/ASN.2011060614
61. Johnson RJ, Floege J, Yoshimura A et al (1992) The activated mesangial cell: a glomerular “myofibroblast”? J Am Soc Nephrol 2:S190–S197
62. Reiser J, Sever S (2012) Podocyte biology and pathogenesis of kidney disease. Annu Rev Med. doi:10.1146/annurev-med-050311-163340
63. Jefferson JA, Alpers CE, Shankland SJ (2011) Podocyte biology for the bedside. Am J Kidney Dis 58:835–845. doi:10.1053/j.ajkd.2011.03.033
64. Kobayashi A, Valerius MT, Mugford JW et al (2008) Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3:169–181. doi:10.1016/j.stem.2008.05.020
65. Brunskill EW, Georgas K, Rumballe B et al (2011) Defining the molecular character of the developing and adult kidney podocyte. PLoS One 6:e24640. doi:10.1371/journal.pone.0024640
66. Hutchison N, Fligny C, Duffield JS (2012) Resident mesenchymal cells and fibrosis. Biochim Biophys Acta. doi:10.1016/j.bbadis.2012.11.015